Anderson ME (1985) Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 113:548–555

CAS  PubMed  Google Scholar 

Armstrong RN (1991) Glutathione S-transferases: reaction mechanism, structure, and function. Chem Res Toxicol 4:131–140

CAS  PubMed  Google Scholar 

Bai F, Lau SS, Monks TJ (1999) Glutathione and N-acetylcysteine conjugates of α-methyldopamine produce serotoninergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity. Chem Res Toxicol 12:1150–1157

CAS  PubMed  Google Scholar 

Bai F, Jones DC, Lau SS, Monks TJ (2001) Serotonergic neurotoxicity of 3,4-(±)-methylenedioxyamphetamine and 3,4-(±)-methylenedioxymethamphetamine (Ecstasy) is potentiated by inhibition of γ-glutamyl transpeptidase. Chem Res Toxicol 14:863–870

Article  CAS  PubMed  Google Scholar 

Battaglia G, Yeh SY, O’Hearn E, Molliver ME, Kuhar MJ, Sousa EBD (1987) 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [³H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242:911–916

CAS  PubMed  Google Scholar 

Beitia G, Cobreros A, Sainz L, Cenarruzabeitia E (1999) 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes. Liver 19:234–241

CAS  PubMed  Google Scholar 

Ben-Shachar D, Riederer P, Youdim MB (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson’s disease. J Neurochem 57:1609–1614

CAS  PubMed  Google Scholar 

Bindoli A, Rigobello MP, Galzigna L (1989) Toxicity of aminochromes. Toxicol Lett 48:3–20

Article  CAS  PubMed  Google Scholar 

Bindoli A, Rigobello MP, Deeble DJ (1992) Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 13:391–405

Article  CAS  PubMed  Google Scholar 

Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ (2000) Role of quinones in toxicology. Chem Res Toxicol 13:135–160

Article  CAS  PubMed  Google Scholar 

Carstam R, Brinck C, Hindemith-Augustsson A, Rorsman H, Rosengren E (1991) The neuromelanin of the human substancia nigra. Biochim Biophys Acta 1097:152–160

Article  CAS  PubMed  Google Scholar 

Carvalho F, Remião F, Soares ME, Catarino R, Queiroz G, Bastos ML (1997) d-Amphetamine-induced hepatotoxicity: possible contribution of catecholamines and hyperthermia to the effect studied in isolated rat hepatocytes. Arch Toxicol 71:429–436

Article  CAS  PubMed  Google Scholar 

Carvalho M, Carvalho F, Bastos ML (2001) Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes. Arch Toxicol 74:789–793

CAS  PubMed  Google Scholar 

Carvalho M, Carvalho F, Remião F, Pereira MdL, Pires-das-Neves R, Bastos MdL (2002a) Effect of 3,4-methylenedioxymethamphetamine (“ecstasy”) on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol 76:166–172

Article  CAS  PubMed  Google Scholar 

Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks T, Fernandes E, Carvalho F, Bastos ML (2002b) Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch Toxicol 76:581–588

Article  CAS  PubMed  Google Scholar 

Cho AK, Hiramatsu M, Distefano EW, Chang AS, Jenden DJ (1990) Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis. Drug Metab Dispos 18:686–691

CAS  PubMed  Google Scholar 

DeLeve LD, Kaplowitz N (1991) Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 52:287–305

CAS  PubMed  Google Scholar 

Di Mascio P, Murphy ME, Sies H (1991) Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols. Am J Clin Nutr 53:194S–200S

PubMed  Google Scholar 

Dykhuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith CC (1995) Ecstasy induced hepatitis mimicking viral hepatitis. Gut 36:939–941

CAS  PubMed  Google Scholar 

Ellis A, Wendon J, Portmann B, Williams R (1996) Acute liver damage and ecstasy ingestion. Gut 38:454–458

CAS  PubMed  Google Scholar 

Fineschi V, Centini F, Mazzeo E, Turillazzi E (1999) Adam (MDMA) and Eve (MDA) misuse: an immunohistochemical study on three fatal cases. Forensic Sci Int 104:65–74

CAS  PubMed  Google Scholar 

Hegadoren KM, Baker GB, Bourin M (1999) 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans. Neurosci Biobehav Rev 23:539–553

CAS  PubMed  Google Scholar 

Hegedus ZL (2000) The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging. Toxicology 145:85–101

Article  CAS  PubMed  Google Scholar 

Henry JA, Jeffreys KJ, Dawling S (1992) Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 340:384–387

CAS  PubMed  Google Scholar 

Hiramatsu M, Kumagai Y, Unger SE, Cho AK (1990) Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther 254:521–527

CAS  PubMed  Google Scholar 

Khakoo S, Coles C, Armstrong J, Barry R (1995) Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymethamphetamine (“ecstasy”) usage. J Clin Gastroenterol 20:244–247

CAS  PubMed  Google Scholar 

Kreth K-P, Kovar K-A, Schwab M, Zanger UM (2000) Identification of the human cytochromes P450 involved in the oxidative metabolism of “ecstasy”-related designer drugs. Biochem Pharmacol 59:1563–1571

CAS  PubMed  Google Scholar 

Kumagai Y, Lin LY, Schmitz DA, Cho AK (1991) Hydroxyl radical mediated demethylenation of (methylenedioxy)phenyl compounds. Chem Res Toxicol 4:330–334

CAS  PubMed  Google Scholar 

Lim HK, Foltz RL (1988) In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector. Chem Res Toxicol 1:370–378

CAS  PubMed  Google Scholar 

Mannervik B, Danielson UH (1988) Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem 23:283–337

CAS  Google Scholar 

Marquardt GM, DiStefano V, Ling LL (1978) Metabolism of β-3,4-methylenedioxyamphetamine in the rat. Biochem Pharmacol 27:1503–1505

Article  CAS  PubMed  Google Scholar 

Miller RT, Lau SS, Monks TJ (1995) Metabolism of 5-(glutathion-S-yl)-α-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats. Chem Res Toxicol 8:634–641

CAS  PubMed  Google Scholar 

Miller RT, Lau SS, Monks TJ (1996) Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-α-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats. Chem Res Toxicol 9:457–465

Article  CAS  PubMed  Google Scholar 

Miller RT, Lau SS, Monks TJ (1997) 2,5-bis-(glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations. Eur J Pharmacol 323:173–180

CAS  PubMed  Google Scholar 

Milroy CM, Clark JC, Forrest ARW (1996) Pathology of deaths associated with “ecstasy” and “eve” misuse. J Clin Pathol 49:149–153

CAS  PubMed  Google Scholar 

Moldéus P, Hogberg J, Orrenius S (1978) Isolation and use of liver cells. Methods Enzymol 52:60–71

PubMed  Google Scholar 

Monks TJ, Lau SS (1992) Toxicology of quinone-thioethers. Crit Rev Toxicol 22:243–270

CAS  PubMed  Google Scholar 

Ommen BV, Ploemen JHTM, Bogaards JJP, Monks TJ, Lau SS, Bladeren PJV (1991) Irreversible inhibition of rat glutathione S-transferase 1-1 by quinones and their glutathione conjugates. Structure–activity relationship and mechanism. Biochem J 276:661–666

PubMed  Google Scholar 

Ploemen JH, Ommen BV, Bladeren PJV (1991) Irreversible inhibition of human glutathione S-transferase isoenzymes by tetrachloro-1,4-benzoquinone and its glutathione conjugate. Biochem Pharmacol 41:1665–1669

Article  CAS  PubMed  Google Scholar 

Ploemen JH, Ommen BV, Haan AD, Venekamp JV, Bladeren PJV (1994) Inhibition of human glutathione S-transferases by dopamine, α-methyldopa and their 5-S-glutathionyl conjugates. Chem Biol Interact 90:87–99

Article  CAS  PubMed  Google Scholar 

Reed DJ (1990) Glutathione: toxicological implications. Annu Rev Toxicol 30:603–631

Article  CAS  Google Scholar 

Remião F, Carmo H, Carvalho FD, Bastos ML (1999) Inhibition of glutathione reductase by isoproterenol oxidation products. J Enzyme Inhib 15:47–61

PubMed  Google Scholar 

Remião F, Carvalho M, Carmo H, Carvalho FD, Bastos ML (2002) Cu²⁺-induced isoproterenol oxidation into isoprenochrome in adult rat calcium-tolerant cardiomyocytes. Chem Res Toxicol 15:861–869

Article  PubMed  Google Scholar 

Ricaurte GA, Yuan J, McCann UD (2000) (±)3,4-Methylenedioxymethamphetamine (“ecstasy”)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5–10

CAS  PubMed  Google Scholar 

Simpson DL, Rumack BH (1981) Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology. Arch Intern Med 141:1507–1509

Google Scholar 

Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem 71:2112–2122

CAS  PubMed  Google Scholar 

van Bladeren PJ (2000) Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 129:61–76

PubMed  Google Scholar 

Varela-Rey M, Montiel-Duarte C, Beitia G, Cenarruzabeitia E, Iraburu MJ (1999) 3,4-Methylenedioxymethamphetamine (“ecstasy”) stimulates the expression of α1 (I) procollagen mRNA in hepatic stellate cells. Biochem Biophys Res Commun 259:678–682

Article  CAS  PubMed  Google Scholar 

Walubo A, Seger D (1999) Fatal multi-organ failure after suicidal overdose with MDMA, “ecstasy”: case report and review of the literature. Hum Exp Toxicol 18:119–125

CAS  PubMed  Google Scholar 

Zhang F, Dryhurst G (1994) Effects of l-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson’s disease. J Med Chem 37:1084–1098

CAS  PubMed  Google Scholar